Interstitial Lung Disease Trial, Recruiting (NCT05392881)

Interstitial Lung Disease Trial, Recruiting NCT05392881 Sponsor: University of Kansas Medical Center Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05392881 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a patient at The University of Kansas Health System (TUKHS), or you have agreed to take part in a study approved by the University of Kansas Medical Center's research protection program
You are being seen and monitored for an autoimmune disease, interstitial lung disease (ILD), or another rare lung disease at TUKHS
You are 18 years of age or older
You have signed an approved consent form to participate in this study (this applies to living patients only)

Who may not be able to join:

There are no specific exclusion criteria listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Scott Matson, M.D., University of Kansas Medical Center

Phone: 913-588-6067

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05392881

Sponsor: University of Kansas Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

Trial contact: 913-588-6067

More information: https://clinicaltrials.gov/study/NCT05392881

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a patient at The University of Kansas Health System (TUKHS), or you have agreed to take part in a study approved by the University of Kansas Medical Center's research protection program
You are being seen and monitored for an autoimmune disease, interstitial lung disease (ILD), or another rare lung disease at TUKHS
You are 18 years of age or older
You have signed an approved consent form to participate in this study (this applies to living patients only)

Who may not be able to join:

There are no specific exclusion criteria listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Kansas Medical Center

Registry

ClinicalTrials.gov

Start date

9 August 2021

Est. completion

1 August 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Collect clinically obtained data for patients with ILD, RLD and risk for ILD/RLD to support research.; Establish a collection of biological samples from patients with ILD, RLD and subjects at risk for ILD.; Correlate biological samples with individual longitudinal clinical data.; Provide biological samples to researchers performing studies in ILD and RLD.; Collect historical data and imaging from deceased patients with ILD.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov